Lipitor and Intron a drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Intron a (interferon alfa-2b). Common drug interactions include headache among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Intron a. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,050 Lipitor users. Check the latest studies of Lipitor.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

50 people who take Lipitor and Intron a together, and have interactions are studied.

Lipitor and Intron a drug interactions.

What are the common drug interactions of Lipitor and Intron A, by gender? *:

female:

  1. Headache (pain in head)
  2. Herpes zoster
  3. Kidney infection
  4. Myalgia (muscle pain)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain in extremity
  7. Pain in limb
  8. White blood cell count decreased
  9. Adverse event
  10. Activities of daily living impaired

male:

  1. Weight decreased
  2. Diarrhoea
  3. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Loss of consciousness
  6. Pleural effusion (water on the lungs)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Abdominal discomfort
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Lipitor and Intron A, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Pain in limb
  3. Heat exhaustion (dizziness and nausea and weakness caused by depletion of body fluids and electrolytes)
  4. Heat stroke
  5. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

40-49:

  1. Blindness
  2. Blood amylase increased
  3. Blood in stool
  4. Chest pain
  5. Chest tightness
  6. Confusion
  7. Depression
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  9. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

50-59:

  1. Application site urticaria
  2. Application site vesicles (small bubble within a cell at application site)
  3. Atherosclerosis (disorder of the arteries)
  4. Capillary leak syndrome (capillary leaks plasma)
  5. Cardiac failure congestive
  6. Death
  7. Dehydration (dryness resulting from the removal of water)
  8. Diarrhoea
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  10. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Weight decreased
  2. Renal cyst (kidney cyst)
  3. Abdominal discomfort
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anaemia (lack of blood)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Back pain
  9. Bone disorder
  10. Bowel movement irregularity

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 10 people, 20.00%
  2. Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 5 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Intron a?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Intron a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Intron a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intron a and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and interferon alfa-2b (the active ingredients of Lipitor and Intron a, respectively), and Lipitor and Intron a (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: